{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T16:55:09Z","timestamp":1790096109585,"version":"4.0.1"},"reference-count":24,"publisher":"Public Library of Science (PLoS)","issue":"2","license":[{"start":{"date-parts":[[2018,2,28]],"date-time":"2018-02-28T00:00:00Z","timestamp":1519776000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0193043","type":"journal-article","created":{"date-parts":[[2018,2,28]],"date-time":"2018-02-28T13:39:11Z","timestamp":1519825151000},"page":"e0193043","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":9,"title":["Does the rising placebo response impact antihypertensive clinical trial outcomes? An analysis of data from the Food and Drug Administration 1990-2016"],"prefix":"10.1371","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9510-6083","authenticated-orcid":true,"given":"Arif","family":"Khan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaysee","family":"Fahl Mar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua","family":"Schilling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Walter A.","family":"Brown","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2018,2,28]]},"reference":[{"issue":"3","key":"ref1","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1192\/bjp.178.3.192","article-title":"Placebo response in depression: bane of research, boon to therapy","volume":"178","author":"G. Andrews","year":"2001","journal-title":"Br J Psychiatr"},{"issue":"14","key":"ref2","doi-asserted-by":"crossref","first-page":"1840","DOI":"10.1001\/jama.287.14.1840","article-title":"Placebo response in studies of major depression: variable, substantial, and growing","volume":"287","author":"BT Walsh","year":"2001","journal-title":"JAMA"},{"issue":"4","key":"ref3","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1097\/01.NMD.0000061144.16176.38","article-title":"Placebo response and antidepressant clinical trial outcome","volume":"191","author":"A Khan","year":"2003","journal-title":"J Nerv Ment Dis"},{"issue":"2","key":"ref4","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1002\/wps.20421","article-title":"Has the rising placebo response impacted antidepressant clinical trial outcome? Data from the US Food and Drug Administration 1987\u20132013","volume":"16","author":"A Khan","year":"2017","journal-title":"World Psychiatry"},{"key":"ref5","first-page":"202","article-title":"Does the increasing magnitude of placebo response affect outcome of adult and pediatric ADHD clinical trials?","volume":"94","author":"A Khan","year":"2017","journal-title":"J of Psychiatric Res"},{"key":"ref6","article-title":"Magnitude and pattern of placebo response in clinical trials of antiepileptic medications: Data from the Food and Drug Administration 1996\u20132016","author":"A Khan","year":"2018","journal-title":"Contemporary Clinical Trials"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2337\/dc17-1316","article-title":"Magnitude and pattern of placebo response in clinical trials of oral antihyperglycemic agents: Data from the Food and Drug Administration 1999\u20132015","volume":"41","author":"A Khan","year":"2018","journal-title":"Diabetes Care"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1016\/S2215-0366(16)30307-8","article-title":"Placebo response rates in antidepressant trials: a systematic review of published and unpublished double-blind randomised controlled studies","volume":"3","author":"TA Furukawa","year":"2016","journal-title":"The Lancet Psychiatry"},{"issue":"12","key":"ref9","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1016\/j.jash.2016.10.009","article-title":"Effect of placebo groups on blood pressure in hypertension: meta-analysis of beta-blocker trials","volume":"10","author":"M Wilhelm","year":"2016","journal-title":"J Am Soc Hypertens"},{"issue":"2","key":"ref10","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1161\/HYPERTENSIONAHA.114.04640","article-title":"Magnitude of blood pressure reduction in the placebo arms of modern hypertension trials: implications for trials of renal denervation","volume":"65","author":"HC Patel","year":"2015","journal-title":"Hypertens"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1001\/archinte.160.10.1449","article-title":"Placebo-associated blood pressure response and adverse effects in the treatment of hypertension: observations from a department of Veterans Affairs Cooperative Study","volume":"160","author":"RA Preston","year":"2000","journal-title":"Arch Intern Med"},{"issue":"6","key":"ref12","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1080\/080370500300000914","article-title":"The placebo effect and white coat effect in isolated systolic hypertension s and systo-diastolic hypertension","volume":"9","author":"DC Felmeden","year":"2000","journal-title":"Blood Pressure"},{"key":"ref13","first-page":"353","article-title":"Blood pressure monitoring in cardiovascular medicine and therapeutics","author":"GS Stergiou","year":"2016"},{"issue":"2","key":"ref14","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/S0895-7061(01)02324-X","article-title":"Reproducibility of home, ambulatory, and clinic blood pressure: implications for the design of trials for the assessment of antihypertensive drug efficacy","volume":"12","author":"GS Stergiou","year":"2002","journal-title":"Am J Hypertens"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/S0895-7061(00)01286-3","article-title":"Evaluation of the placebo effect and reproducibility of blood pressure measurement in hypertension","volume":"14","author":"R Asmar","year":"2001","journal-title":"Am J Hypertens"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1016\/S0140-6736(81)92799-9","article-title":"Does placebo lower blood pressure?","volume":"8261","author":"BA Gould","year":"1981","journal-title":"The Lancet"},{"issue":"9","key":"ref17","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1097\/00004872-199409000-00007","article-title":"Ambulatory pressure decreases on long-term placebo treatment in older patients with isolated systolic hypertension","volume":"12","author":"JA Staessen","year":"1994","journal-title":"J Hypertens"},{"issue":"6","key":"ref18","first-page":"633","article-title":"Placebo effect and adaptation to noninvasive monitoring of BP","volume":"4","author":"M Antivalle","year":"1990","journal-title":"J Hum Hypertens"},{"issue":"6","key":"ref19","first-page":"567","article-title":"Effect of placebo on office and on 24 hour noninvasive ambulatory blood pressure measurements","volume":"7","author":"E Paran","year":"1993","journal-title":"J Hum Hypertens"},{"key":"ref20","unstructured":"Food and Drug Administration. FDA Access Data; 2016 [cited July 2017]. Database: [Internet]. <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.accessdata.fda.gov\/\" xlink:type=\"simple\">http:\/\/www.accessdata.fda.gov\/<\/ext-link>."},{"key":"ref21","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1056\/NEJMsa065779","article-title":"Selective publication of antidepressant trials and its influence on apparent efficacy","volume":"358","author":"EH Turner","year":"2008","journal-title":"New Engl J Med"},{"issue":"7","key":"ref22","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1176\/appi.ajp.2012.12040474","article-title":"A model of placebo response in antidepressant clinical trials","volume":"170","author":"BR Rutherford","year":"2013","journal-title":"Am J Psychiatry"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1176\/appi.ajp.161.11.2045","article-title":"Research design features and patient characteristics associated with the outcome of antidepressant clinical trials","volume":"161","author":"A Khan","year":"2004","journal-title":"Am J Psychiatry"},{"issue":"1","key":"ref24","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.euroneuro.2008.08.009","article-title":"Does the probability of receiving placebo influence clinical trial outcome? A meta-regression of double-blind, randomized clinical trials in MDD","volume":"19","author":"GI Papakostas","year":"2009","journal-title":"Eur Neuropsychopharmacol"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0193043","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,11]],"date-time":"2019-10-11T21:58:06Z","timestamp":1570831086000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0193043"}},"subtitle":[],"editor":[{"given":"Dermot","family":"Cox","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2018,2,28]]},"references-count":24,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2018,2,28]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0193043","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,2,28]]}}}